|
Volumn 54, Issue 3, 2006, Pages 549-550
|
Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PEGINTERFERON;
RIBAVIRIN;
TRAZODONE;
AGE DISTRIBUTION;
AGED;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEPRESSION;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TOLERABILITY;
FEMALE;
GENOTYPE;
HEPATITIS C;
HUMAN;
LETTER;
MALE;
SEX DIFFERENCE;
VIRUS LOAD;
AGE FACTORS;
AGED;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
MALE;
MIDDLE AGED;
RIBAVIRIN;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 33644653236
PISSN: 00028614
EISSN: 15325415
Source Type: Journal
DOI: 10.1111/j.1532-5415.2006.00643_4.x Document Type: Letter |
Times cited : (35)
|
References (7)
|